Cardiovascular Research Institute of Dallas
Dallas, Texas 75231
0 studies enrolling now · 17 studies all time
What they study most
Acute Coronary Syndrome, Atrial Fibrillation, Atrial Flutter, Cardiomyopathy, Cardiovascular Disease, Cardiovascular Diseases, Chronic Heart Failure, Congestive Heart Failure, Coronary Stenosis, Heart Diseases, Heart Failure, Heart Failure, Congestive
Studies at this site
- Baroreflex Activation Therapy for Heart Failure — Completed
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
- Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE) — Completed
- Cardiovascular Inflammation Reduction Trial — Completed
- The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator — Completed
- The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System — Completed
- Atrium iCAST Iliac Stent Pivotal Study — Completed
- Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery — Completed
- Phase III Acute Coronary Syndrome — Stopped early
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
- Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure — Completed
- Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure — Completed
- Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions — Completed
- Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation — Status unconfirmed
- Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed